Plumb Pharmaceuticals
Madison
About Plumb Pharmaceuticals
Plumb Pharmaceuticals produces super-extended-release formulations of weak-base, small-molecule pharmaceuticals using creative quantload technologies that were developed by the company. By providing stimulants for the treatment of ADHD, anti-HIV medications, antibiotics, antipsychotics, cancer chemotherapeutic agents, antihistamines, and analgesics, the company's lipid nanoparticle technology enables the healthcare sector to enhance people's health.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $324.9K
- Funding stage: Seed
- Last round: Seed (Apr 2024)
- Website: plumbpharma.com
- Phone: 608-220-5531
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/plumb-pharmaceuticals-74881 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.